510(k) Report

510(k) · Cleared

Cleared

Diazyme Carbon Dioxide Enzymatic Assay Kit, Model KZ122A

K060619510(k) TraditionalCleared Jul 21, 2006135-day reviewClass II21 CFR 862.1160

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diazyme Laboratories · KHS Enzymatic, Carbon-Dioxide

Cleared on Jul 21, 2006 as substantially equivalent to K990754 (Diagnostic Chemicals, Ltd., 1999) after a 135-day review. Its family tree reaches back 1 generation to 1999.

Decided
Jul 21, 2006
Review
135 days
Class
Class II
Product code
KHS
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K990754 (1999). No later device cites it as a predicate yet.

K990754 · Carbon Dioxide - L3K Assay, Catalogue Number 299-30/40/50 · Diagnostic Chemicals, Ltd. · 19991996199820002002200420062008
  1. Root · 1 generation backK990754 Carbon Dioxide - L3K Assay, Catalogue Number 299-30/40/50Diagnostic Chemicals, Ltd. · 1999
  2. This deviceK060619 Diazyme Carbon Dioxide Enzymatic Assay Kit, Model KZ122ADiazyme Laboratories · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K990754Carbon Dioxide - L3K Assay, Catalogue Number 299-30/40/50Diagnostic Chemicals, Ltd.1999—
0 (this device)K060619Diazyme Carbon Dioxide Enzymatic Assay Kit, Model KZ122ADiazyme Laboratories2006—
FIG. 1 — Lineage of K060619, 1999–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KHS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K990754Carbon Dioxide - L3K Assay, Catalogue Number 299-30/40/50
Summary page 1
…iming equivalence [807.92(a)(3)]: CARBON DIOXIDE-L3K ASSAY (k990754) manufactured by Diagnostic Chemicals Limited, Oxford, CT, USA.…
Diagnostic Chemicals, Ltd.1999—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All KHS devices

KHS Enzymatic, Carbon-Dioxide: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KHS

1in 2017

2007: 22008: 12009: 12010: 32011: 12012: 22013: 22014: 12016: 12017: 1
2007high 3 (2010) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KHS

143in 2010

2010: 143 days median
2007high 143 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KHS

1in 2025

2013: 12019: 12023: 12025: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KHS

40in 2025

2008: 22009: 142011: 52012: 32013: 22014: 62015: 12016: 42017: 72018: 152019: 352020: 312021: 142022: 102023: 252024: 302025: 40
2007high 40 (2025) · low 0 (2007)2025

MAUDE reports naming product code KHS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—02
20091—014
2010314300
20111—05
20122—03
20132—12
20141—06
20150—01
20161—04
20171—07
20180—015
20190—135
20200—031
20210—014
20220—010
20230—125
20240—030
20250—140
20260—0—

What is it indicated for?

Diazyme Carbon Dioxide Enzymatic Assay Kit, in conjunction with Diazyme Carbon Dioxide Calibrator, are intended for the quantitative determination of carbon dioxide (CO 2) in serum and plasma. Diazyme Carbon Dioxide Enzymatic Assay Kit contains a single-point calibrator. The calibrator, along with 0.9% saline as a zero reference, is used to generate a linear graph that will be used in the calculation of carbon dioxide concentrations in unknown samples.

Diazyme Carbon Dioxide Control Set has controls for normal carbon dioxide level and abnormal carbon dioxide level. The controls are used as reference samples for checking the functionality of the Diazyme Carbon Dioxide Enzymatic Assay.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060619: Diazyme Carbon Dioxide Enzymatic Assay Kit, Model KZ122A.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K060619

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026